Biotechnology stocks
Browse Biotechnology companies ranked by market cap with quality stock ratings for context.
Last updated on July 27, 2026
How this screen worksEvery company below clears all two criteria
IndustryBiotechnology
SortMarket cap, largest first
Biotechnology stocks
Top 50 of 609 companies
Quality rating| Company | Sector | Market cap | Quality rating | |
|---|---|---|---|---|
| Novo Nordisk | Healthcare | $221.8B | 9.4 | |
| Vertex Pharmaceuticals | Healthcare | $121.6B | 9.6 | |
| Regeneron Pharmaceuticals | Healthcare | $69.9B | 9.4 | |
| Argenx | Healthcare | $55.6B | 2.3 | |
| Revolution Medicines | Healthcare | $40.0B | 1.7 | |
| Alnylam Pharmaceuticals | Healthcare | $37.2B | 8.5 | |
| Beone Medicines | Healthcare | $36.3B | 6.2 | |
| Royalty Pharma | Healthcare | $33.8B | 4.3 | |
| Roivant Sciences | Healthcare | $25.0B | 1.6 | |
| Incyte | Healthcare | $23.7B | 9.1 | |
| Insmed | Healthcare | $22.7B | 2.2 | |
| United Therapeutics | Healthcare | $22.4B | 10 | |
| Moderna | Healthcare | $22.1B | 3.0 | |
| Biontech | Healthcare | $21.9B | 6.3 | |
| Genmab A | Healthcare | $18.5B | 8.9 | |
| Bridgebio Pharma | Healthcare | $16.5B | 2.3 | |
| Jazz Pharmaceuticals | Healthcare | $16.0B | 7.4 | |
| Ascendis Pharma A | Healthcare | $15.7B | 3.1 | |
| Exelixis | Healthcare | $14.0B | 10 | |
| Madrigal Pharmaceuticals | Healthcare | $12.7B | 3.2 | |
| Axsome Therapeutics | Healthcare | $12.3B | 3.2 | |
| Arrowhead Pharmaceuticals | Healthcare | $12.0B | 4.6 | |
| Biomarin Pharmaceutical | Healthcare | $11.6B | 5.4 | |
| Bio-Techne | Healthcare | $11.2B | 8.6 | |
| Summit Therapeutics | Healthcare | $10.5B | 0.3 | |
| Krystal Biotech | Healthcare | $10.4B | 7.7 | |
| Apogee Therapeutics | Healthcare | $10.1B | 0.7 | |
| Abivax | Healthcare | $10.1B | 0.5 | |
| Cytokinetics | Healthcare | $10.0B | 2.2 | |
| Corcept Therapeutics | Healthcare | $9.8B | 8.8 | |
| Halozyme Therapeutics | Healthcare | $9.7B | 9.2 | |
| Ionis Pharmaceuticals | Healthcare | $9.2B | 4.0 | |
| Kymera Therapeutics | Healthcare | $9.1B | 1.1 | |
| Crinetics Pharmaceuticals | Healthcare | $8.8B | 1.6 | |
| Praxis Precision Medicines | Healthcare | $8.8B | 0.6 | |
| Protagonist Therapeutics | Healthcare | $8.7B | 3.1 | |
| Spyre Therapeutics | Healthcare | $8.7B | 0.7 | |
| Tg Therapeutics | Healthcare | $8.5B | 5.6 | |
| Immunovant | Healthcare | $8.2B | 0.7 | |
| Vaxcyte | Healthcare | $8.0B | 1.9 | |
| Liquidia | Healthcare | $7.5B | 4.2 | |
| Immunitybio | Healthcare | $7.3B | 1.4 | |
| Rhythm Pharmaceuticals | Healthcare | $7.3B | 2.6 | |
| Mirum Pharmaceuticals | Healthcare | $7.0B | 4.2 | |
| Cogent Biosciences | Healthcare | $6.9B | 0.4 | |
| Cg Oncology | Healthcare | $6.5B | 0.8 | |
| Xenon Pharmaceuticals | Healthcare | $6.4B | 0.7 | |
| Ptc Therapeutics | Healthcare | $6.3B | 4.5 | |
| Belite Bio | Healthcare | $6.2B | 0.8 | |
| Ligand Pharmaceuticals | Healthcare | $6.0B | 4.7 |
Showing the top 50 of 609 matches.
See all 609 in the screener